You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

E-Z SCRUB Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do E-z Scrub patents expire, and when can generic versions of E-z Scrub launch?

E-z Scrub is a drug marketed by Becton Dickinson and is included in four NDAs.

The generic ingredient in E-Z SCRUB is povidone-iodine. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the povidone-iodine profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for E-Z SCRUB?
  • What are the global sales for E-Z SCRUB?
  • What is Average Wholesale Price for E-Z SCRUB?
Summary for E-Z SCRUB
US Patents:0
Applicants:1
NDAs:4
Raw Ingredient (Bulk) Api Vendors: 80
Patent Applications: 2,896
DailyMed Link:E-Z SCRUB at DailyMed
Drug patent expirations by year for E-Z SCRUB

US Patents and Regulatory Information for E-Z SCRUB

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Becton Dickinson E-Z SCRUB chlorhexidine gluconate SPONGE;TOPICAL 073416-001 Mar 14, 2000 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Becton Dickinson E-Z SCRUB 241 povidone-iodine SPONGE;TOPICAL 019476-001 Jan 7, 1987 DISCN Yes No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Becton Dickinson E-Z SCRUB hexachlorophene SPONGE;TOPICAL 017452-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Becton Dickinson E-Z SCRUB 201 povidone-iodine SPONGE;TOPICAL 019240-001 Nov 29, 1985 DISCN Yes No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

E-Z SCRUB Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for E-Z SCRUB

Introduction to E-Z SCRUB

E-Z SCRUB, a product line by BD, is a series of preoperative surgical scrub brushes designed to reduce the risk of contamination by microorganisms during surgical procedures. These brushes are impregnated with various antimicrobial formulations, including chlorhexidine gluconate (CHG), chloroxylenol (PCMX), and povidone-iodine (PVP-I)[1].

Market Growth Drivers

Increasing Surgical Procedures and Accidents

The surgical scrub market, which includes products like E-Z SCRUB, is driven by the rising number of surgeries and accidents. According to recent reports, the number of physician office visits for unintentional injuries in the United States was 24.8 million in 2018, contributing significantly to the demand for surgical scrubs[2].

Health Hygiene Awareness

Growing awareness about health hygiene, particularly the use of sanitizers and gel scrubs to protect against germs, has also boosted the market growth. This increased awareness is fueled by campaigns from global health organizations such as the World Health Organization (WHO) and the Food and Drug Administration (FDA)[2].

Geriatric Population and Chronic Diseases

The growing geriatric population and the rising prevalence of chronic diseases are additional factors driving the demand for surgical scrubs. As the population ages and chronic diseases become more common, the need for surgical procedures increases, thereby boosting the market for products like E-Z SCRUB[2].

Market Segmentation

By Type

The surgical scrub market is segmented into waterless, water-based, and other types. E-Z SCRUB falls under the water-based category, which is a significant segment due to its effectiveness in removing microorganisms. The market value and forecast for these segments indicate a steady growth trajectory, with water-based scrubs expected to maintain a substantial market share[2].

By Application

The market is also segmented by application, including removing microorganisms, removing resident microbial flora, and other applications. E-Z SCRUB is primarily used to remove microorganisms, a segment that is expected to see significant growth due to the increasing need for infection control measures[2].

Financial Trajectory

Market Size and Forecast

The surgical scrub market, which includes E-Z SCRUB, accounted for US$ 209.4 million in 2022 and is estimated to reach US$ 339.5 million by 2032, registering a Compound Annual Growth Rate (CAGR) of 4.7%[2].

Regional Performance

The market is segmented by region, with North America and Europe expected to remain dominant due to high healthcare spending and established healthcare infrastructure. The Asia Pacific region is anticipated to experience the highest growth due to the increasing number of surgeries and rising awareness about infection control measures[2].

Competitive Landscape

Key Players

The surgical scrub market is competitive, with major players including 3M Company, STERIS Life Sciences, BD, and Ecolab. These companies are vying to establish their position through innovative products and strategic market approaches. BD, the manufacturer of E-Z SCRUB, is a significant player in this market, leveraging its market-leading products and services to advance healthcare practices[2].

Regulatory and Health Trends

Infection Control Measures

The emphasis on infection control measures by regulatory bodies such as the Centers for Disease Control and Prevention (CDC) and WHO has been a key driver for the adoption of surgical scrubs. These measures are crucial in reducing hospital-acquired infections, which is a major concern in healthcare settings[2].

Government Spending and Healthcare Infrastructure

Increasing government spending on improving healthcare infrastructure and delivering high-quality treatment also supports the growth of the surgical scrub market. This investment in healthcare infrastructure enhances the demand for products like E-Z SCRUB, which are essential for maintaining hygiene standards during surgical procedures[2].

Key Takeaways

  • Growing Demand: The surgical scrub market is driven by the increasing number of surgeries, accidents, and the need for infection control.
  • Segmentation: The market is segmented by type (waterless, water-based) and application (removing microorganisms, resident microbial flora), with E-Z SCRUB falling under the water-based category.
  • Financial Trajectory: The market is expected to grow from US$ 209.4 million in 2022 to US$ 339.5 million by 2032, with a CAGR of 4.7%.
  • Regional Performance: North America and Europe are dominant, while the Asia Pacific region is expected to see the highest growth.
  • Competitive Landscape: Major players include 3M, STERIS, BD, and Ecolab, with BD being a significant player.

FAQs

What are the primary antimicrobial formulations used in E-Z SCRUB?

E-Z SCRUB brushes are impregnated with chlorhexidine gluconate (CHG), chloroxylenol (PCMX), and povidone-iodine (PVP-I)[1].

What are the key drivers of the surgical scrub market?

The key drivers include the rising number of surgeries and accidents, growing awareness about health hygiene, and increasing government spending on healthcare infrastructure[2].

Which regions are expected to dominate the surgical scrub market?

North America and Europe are expected to remain dominant, while the Asia Pacific region is anticipated to experience the highest growth[2].

What is the projected market size of the surgical scrub market by 2032?

The market is estimated to reach US$ 339.5 million by 2032, with a CAGR of 4.7% from 2022 to 2032[2].

Who are the major players in the surgical scrub market?

Major players include 3M Company, STERIS Life Sciences, BD, and Ecolab[2].

Sources

  1. BD E-Z Scrubâ„¢ 107 Surgical Scrub Brush/Sponge, 4% CHG, Red. BD.
  2. Surgical Scrub Market is estimated to be US$ 339.5 million by 2032. EIN Presswire.
  3. Top 10 U.S. Market Access Trends for 2024. IQVIA.
  4. Hexachlorophene: Uses, Interactions, Mechanism of Action. DrugBank.
  5. surgical scrub hats market size and forecast 4. Market Research Intellect.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.